Sterol regulatory element-binding protein 1
Sterol regulatory element-binding protein 1 (SREBP1) is a transcription factor that plays a crucial role in the regulation of lipid metabolism. It is encoded by the SREBF1 gene in humans. SREBP1 is involved in the synthesis of cholesterol, fatty acids, and triglycerides.
Function
SREBP1 is a member of the basic helix-loop-helix leucine zipper (bHLH-Zip) family of transcription factors. It binds to the sterol regulatory element (SRE) in the promoter region of target genes, activating their transcription. This process is essential for maintaining cellular lipid homeostasis.
SREBP1 exists in two isoforms, SREBP1a and SREBP1c, which are generated by alternative splicing. SREBP1c is primarily involved in the regulation of fatty acid synthesis, while SREBP1a has a broader role, influencing both fatty acid and cholesterol synthesis.
Regulation
The activity of SREBP1 is tightly regulated by sterol levels within the cell. Under low sterol conditions, SREBP1 is transported from the endoplasmic reticulum to the Golgi apparatus, where it is cleaved by site-1 and site-2 proteases. The cleaved, active form of SREBP1 then translocates to the nucleus to activate gene expression.
In contrast, high sterol levels inhibit the cleavage and activation of SREBP1, thereby reducing the expression of its target genes and decreasing lipid synthesis.
Clinical Significance
Dysregulation of SREBP1 activity is associated with various metabolic disorders, including obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). Overexpression of SREBP1 can lead to excessive lipid accumulation in tissues, contributing to the development of these conditions.
Research into SREBP1 and its regulatory pathways is ongoing, with the aim of developing therapeutic strategies to modulate its activity in metabolic diseases.
See Also
References
External Links
- [GeneCards: SREBF1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SREBF1)
- [UniProt: P36956](https://www.uniprot.org/uniprot/P36956)
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD